Tender detail
Rebate agreement for medicines containing ixekizumab
Summary
The tender concerns the conclusion of a non-exclusive rebate agreement for medicines containing ixekizumab for the period 01/07/2026 to 30/06/2028. DAK-Gesundheit intends to conclude medicine rebate agreements with as many interested pharmaceutical companies as possible; the agreements start on 01/07/2026 and end on 30/06/2028, or earlier if an exclusive agreement enters into force.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.